AC
Casini, Alessandro
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Management of Young and Ageing Women with Afibrinogenemia and Hypofibrinogenemia | Hämostaseologie |  | 2025 | 28 | 73 | ||
| How I treat quantitative fibrinogen disorders | Blood |  | 2025 | 57 | 0 | ||
| The thrombotic paradox in congenital fibrinogen deficiencies: from pathophysiology to practice | Research and practice in thrombosis and haemostasis | | 2025 | 14 | 10 | ||
| Women and hereditary bleeding disorders | Hämostaseologie | | 2025 | 71 | 235 | ||
| Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database | Research and practice in thrombosis and haemostasis | | 2025 | 23 | 37 | ||
| Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S | Journal of thrombosis and haemostasis | | 2025 | 20 | 0 | ||
| A novel FGG missense variant associated with fibrinogen storage disease in a large family from Quebec | Haemophilia | | 2024 | 76 | 0 | ||
| Perinatal stroke and hypofibrinogenemia : Is the new missense fibrinogen variant γ p.Gly310Glu the cause of the procoagulant state ? | Thrombosis research | | 2024 | 86 | 0 | ||
| Angiologie et hémostase : ce qui a changé en 2023 | Revue médicale suisse | | 2024 | 106 | 14 | ||
| Diagnostic value of clot formation parameters determined by rotational thromboelastometry in 63 patients with congenital dysfibrinogenemia | Blood coagulation & fibrinolysis | | 2024 | 94 | 97 | ||
| Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database | Blood advances | | 2024 | 125 | 69 | ||
| Santé cardiovasculaire et médecine transgenre | Revue médicale suisse | | 2024 | 1 | 0 | ||
| Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature | Research and practice in thrombosis and haemostasis | | 2024 | 119 | 105 | ||
| Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen | Journal of thrombosis and haemostasis | | 2024 | 92 | 0 | ||
| Rare bleeding disorders: Advances in management | Haemophilia | | 2024 | 61 | 240 | ||
| Clinical, laboratory, and molecular aspects of congenital fibrinogen disorders | Seminars in thrombosis and hemostasis | | 2024 | 70 | 0 | ||
| How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause | International journal of laboratory hematology | | 2024 | 83 | 307 | ||
| Saignements utérins anormaux et anomalies de l’hémostase | Revue médicale suisse | | 2024 | 15 | 1 | ||
| Highly thrombogenic phenotype and impaired wound healing in a patient with congenital dysfibrinogenemia : case report | Research and practice in thrombosis and haemostasis | | 2024 | 113 | 61 | ||
| Challenges in the diagnosis and management of patients with rare coagulation disorders in Lebanon and consequences of a social and economic crisis | Haemophilia | | 2024 | 46 | 0 | ||
| 2023 ACR/EULAR antiphospholipid syndrome classification criteria | Annals of the rheumatic diseases | | 2023 | 181 | 615 | ||
| Physiological correction of hereditary mild hypofibrinogenemia during pregnancy | Haemophilia | | 2023 | 216 | 412 | ||
| Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond | Bleeding, thrombosis and vascular biology | | 2023 | 66 | 131 | ||
| Angiologie et hémostase : ce qui a changé en 2022 | Revue médicale suisse | | 2023 | 119 | 63 | ||
| Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology | Swiss medical weekly | | 2023 | 92 | 217 | ||
| Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A | Thrombosis and haemostasis | | 2023 | 176 | 0 | ||
| 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria | Arthritis & rheumatology | | 2023 | 102 | 0 | ||
| High incidence of intracranial haemorrhage in Egyptian children with congenital afibrinogenaemia | Haemophilia | | 2023 | 63 | 0 | ||
| International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders | International journal of laboratory hematology | | 2023 | 85 | 96 | ||
| Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding | Blood coagulation & fibrinolysis | | 2023 | 74 | 0 | ||
| Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders | European journal of haematology | | 2023 | 85 | 177 | ||
| Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives | Blood | | 2023 | 114 | 83 | ||
| Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest Study | Journal of thrombosis and haemostasis | | 2023 | 87 | 0 | ||
| Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive technology | Fertility and sterility | | 2023 | 140 | 0 | ||
| Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial | Thrombosis research | | 2023 | 317 | 68 | ||
| Clinicians’ adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study | BMC Anesthesiology | | 2023 | 92 | 146 | ||
| Fifty years of fibrinogen structure and function | Seminars in thrombosis and hemostasis | | 2023 | 125 | 14 | ||
| Hemizygous FGG p.Ala108Gly in a hypofibrinogenemic patient with a heterozygous 14.8 Mb deletion encompassing the entire fibrinogen gene cluster | Haemophilia | | 2022 | 239 | 2 | ||
| Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort | Blood advances | | 2022 | 282 | 399 | ||
| Angiologie-hémostase - Année 2021 : morceaux choisis | Revue médicale suisse | | 2022 | 97 | 81 | ||
| One Hundred Years of Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | | 2022 | 322 | 0 | ||
| Place des anticoagulants oraux directs dans le traitement des thromboses veineuses de localisation inhabituelle | Revue médicale suisse | | 2022 | 136 | 103 | ||
| Impact of fibrinogen infusion on thrombin generation and fibrin clot structure in patients with inherited afibrinogenemia | Thrombosis and haemostasis | | 2022 | 173 | 2 | ||
| Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial | Research and practice in thrombosis and haemostasis | | 2022 | 245 | 249 | ||
| A homozygous duplication of the FGG exon 8-intron 8 junction causes congenital afibrinogenemia. Lessons learned from the study of a large consanguineous Turkish family | Haematologica | | 2022 | 339 | 188 | ||
| Saignements d’origine indéterminée : approche diagnostique et thérapeutique | Revue médicale suisse | | 2022 | 84 | 206 | ||
| How I treat dysfibrinogenemia | Blood | | 2021 | 345 | 708 | ||
| Novel missense mutations affecting the structure of the conserved fibrinogen Bβ C-terminal domain cause congenital hypofibrinogenemia | Thrombosis Research | | 2021 | 210 | 152 | ||
| Afibrinogenemia with two compound heterozygous mutations in FGA gene | Haemophilia | | 2021 | 280 | 0 | ||
| Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutations | Thrombosis Research | | 2021 | 583 | 4 | ||
| Whole blood thromboelastometry by ROTEM and thrombin generation by genesia according to the genotype and clinical phenotype in congenital fibrinogen disorders | International Journal of Molecular Sciences | | 2021 | 227 | 74 | ||
| Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia | Blood | | 2021 | 288 | 192 | ||
| Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls | Blood Coagulation and Fibrinolysis | | 2021 | 230 | 0 | ||
| Perioperative management of a severe congenital hypofibrinogenemia with thrombotic phenotype | Thrombosis Research | | 2020 | 361 | 46 | ||
| Identification and expression of a novel heterozygous frameshift mutation in FGA accounting for congenital hypofibrinogenemia in carriers of severe hemophilia A | Thrombosis Research | | 2020 | 269 | 2 | ||
| Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines | Swiss Medical Weekly | | 2020 | 540 | 236 | ||
| Risque thrombotique veineux induit par le SARS-CoV-2 : prévalence, recommandations et perspectives | Revue médicale suisse | | 2020 | 344 | 201 | ||
| From Routine to Research Laboratory: Strategies for the Diagnosis of Congenital Fibrinogen Disorders | Hämostaseologie | | 2020 | 274 | 3 | ||
| Fibrin(ogen) in human disease: both friend and foe | Haematologica | | 2020 | 478 | 324 | ||
| A Unique Case of Acquired Hemophilia A Presenting with Transient Ischemic Attack | Acta Haematologica | | 2020 | 337 | 311 | ||
| Contraception et maladie thromboembolique veineuse | Revue médicale suisse | | 2020 | 274 | 210 | ||
| Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 | Swiss Medical Weekly | | 2020 | 364 | 785 | ||
| Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: A retrospective study | European Journal of Gastroenterology and Hepatology | | 2020 | 412 | 525 | ||
| Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland | Swiss Medical Weekly | | 2020 | 616 | 277 | ||
| A novel nonsense mutation in FBG (c.1421G>A;p.Trp474Ter) in the beta chain of fibrinogen causing hypofibrinogenemia with bleeding phenotype | Biomedicines | | 2020 | 279 | 142 | ||
| Molecular characterization of two hypofibrinogenemic patients associated with a novel FGG IVS6+23T>A substitution and a previously reported FGB IVS6-10_16delTTTG deletion | Haemophilia |  | 2020 | 341 | 0 | ||
| Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management | Blood Reviews | | 2020 | 263 | 322 | ||
| Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab | Swiss medical weekly | | 2020 | 197 | 87 | ||
| Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis | Journal of Hepatology | | 2020 | 409 | 107 | ||
| Congenital structural and functional fibrinogen disorders: a primer for internists | Polskie Archiwum Medycyny Wewnetrznej | | 2019 | 545 | 332 | ||
| Fibrinogen concentrates in hereditary fibrinogen disorders: past, present and future | Haemophilia | | 2019 | 308 | 0 | ||
| Obstetrical and postpartum complications in women with hereditary fibrinogen disorders: a systematic literature review | Haemophilia | | 2019 | 430 | 1 | ||
| Impaired factor XIII activation in patients with congenital afibrinogenemia | Haematologica | | 2019 | 356 | 116 | ||
| A unique factor XIII mutation in southeastern Iran with an unexpectedly high prevalence: khash factor XIII | Seminars in Thrombosis and Hemostasis | | 2019 | 375 | 0 | ||
| The impact of haemophilia on the social status and the health-related quality of life in adult Lebanese persons with haemophilia | Haemophilia | | 2019 | 373 | 0 | ||
| Thrombin generation and fibrin clot structure after vitamin D supplementation | Endocrine Connections | | 2019 | 387 | 171 | ||
| Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report | HemaSphere | | 2019 | 271 | 359 | ||
| Hereditary fibrinogen disorders: toward a tailored management | | 2019 | 351 | 13 | |||
| Antithrombotiques dans le syndrome des anticorps antiphospholipides thrombotique | Revue médicale suisse | | 2018 | 355 | 159 | ||
| Clinical Consequences and Molecular Bases of Low Fibrinogen Levels | International Journal of Molecular Sciences | | 2018 | 593 | 239 | ||
| Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis | Thrombosis Research | | 2018 | 469 | 1 | ||
| Mutational epidemiology of congenital fibrinogen disorders | Thrombosis and Haemostasis | | 2018 | 589 | 760 | ||
| Traitements antithrombotiques et anomalies constitutionnelles hémorragipares de l'hémostase | Revue médicale suisse | | 2018 | 373 | 148 | ||
| Acide tranexamique dans la prise en charge de l'hémorragie du postpartum : connaissances actuelles | Revue médicale suisse | | 2018 | 445 | 162 | ||
| A fibrin biofilm covers blood clots and protects from microbial invasion | Journal of Clinical Investigation | | 2018 | 506 | 280 | ||
| Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH | Journal of Thrombosis and Haemostasis | | 2018 | 432 | 87 | ||
| Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization | Haemophilia | | 2017 | 437 | 1 | ||
| Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation | Journal of thrombosis and haemostasis | | 2017 | 614 | 218 | ||
| Thromboses veineuses splanchniques | Revue médicale suisse | | 2017 | 441 | 185 | ||
| A novel fibrinogen mutation: FGA g. 3057 C > T (p. Arg104 > Cys) impairs fibrinogen secretion | BMC Hematology | | 2017 | 454 | 181 | ||
| Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia | Haemophilia | | 2017 | 557 | 4 | ||
| Impact of pneumatic tube system transport for the monitoring of heparin therapy | Thrombosis Research | | 2017 | 464 | 0 | ||
| Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders | Seminars in thrombosis and hemostasis | | 2016 | 582 | 0 | ||
| Pregnancy | Trauma Induced Coagulopathy | | 2016 | 434 | 2 | ||
| Diagnostic des anomalies congénitales du fibrinogène | Annales de biologie clinique | | 2016 | 676 | 1 | ||
| Clinical Features and Management of Congenital Fibrinogen Deficiencies | Seminars in thrombosis and hemostasis | | 2016 | 601 | 5 | ||
| Can the phenotype of inherited fibrinogen disorders be predicted? | Haemophilia | | 2016 | 650 | 2 | ||
| Factor concentrates for rare congenital coagulation disorders: where are we now? | Expert opinion on orphan drugs | | 2016 | 454 | 0 | ||
| Management of congenital quantitative fibrinogen disorders: a Delphi consensus | Haemophilia | | 2016 | 532 | 0 | ||
| Risks of venous thromboembolism after cesarean sections: A meta-analysis | Chest | | 2016 | 488 | 0 | ||
| Congenital Disorders of Fibrinogen: Clinical Presentations, Diagnosis and Management | Nonmalignant Hematology Expert Clinical Review : Questions and Answers | | 2016 | 504 | 0 | ||
| Natural history of patients with congenital dysfibrinogenemia | Blood | | 2015 | 735 | 4 | ||
| Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis | Haemophilia | | 2015 | 519 | 0 | ||
| Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management | Journal of thrombosis and haemostasis | | 2015 | 787 | 552 | ||
| Maladies héréditaires du fibrinogène: de la biologie moléculaire à la clinique | | 2015 | 1,154 | 23 | |||
| Fibrin clot structure in patients with congenital dysfibrinogenaemia | Thrombosis research | | 2015 | 552 | 2 | ||
| Hypofibrinogenemia and liver disease: a new case of Aguadilla fibrinogen and review of the literature | Haemophilia | | 2015 | 591 | 5 | ||
| Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic Malignancies | Bone marrow research | | 2015 | 713 | 328 | ||
| Hémostase. Aspirine: une ou deux fois par jour? | Revue médicale suisse | | 2014 | 582 | 0 | ||
| Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion | Biology of blood and marrow transplantation | | 2014 | 618 | 1 | ||
| Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A | Blood coagulation & fibrinolysis | | 2014 | 656 | 3 | ||
| FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations | Thrombosis research | | 2014 | 690 | 9 | ||
| Acquired factor XIII deficiency: a therapeutic challenge | Thrombosis and haemostasis | | 2013 | 642 | 0 | ||
| Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique | Revue médicale suisse | | 2013 | 410 | 0 | ||
| Pulmonary embolism and fatal stroke in a patient with severe factor XI deficiency after bariatric surgery | Blood coagulation & fibrinolysis | | 2013 | 511 | 0 | ||
| Could Factor XIII be a solution for the management of surgical bleeding? | Management and Severe Bleeding | | 2013 | 375 | 0 | ||
| Congenital fibrinogen disorders: an update | Seminars in thrombosis and hemostasis | | 2013 | 743 | 0 | ||
| Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management | Journal of thrombosis and haemostasis | | 2013 | 686 | 0 | ||
| Thrombophilie : quel bilan en 2012? | La Revue de médecine interne | | 2012 | 499 | 0 | ||
| Recurrent Syncope due to Esophageal Squamous Cell Carcinoma | Case reports in oncology | | 2011 | 692 | 286 |
